Clinical Trial Update: Cognitive Impairment , Neuroimaging and Inflammatory Markers in Patients With Subcortical Ischemic Vascular Disease

View source ↗

Summary

A clinical trial update studying cognitive impairment, neuroimaging, and inflammatory markers in subcortical ischemic vascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cerebrovascular Disease
• Subcortical Ischemic Vascular Disease

Snippet

Sponsor: Hebei General Hospital | Conditions: Other Generalized Ischemic Cerebrovascular Disease | Status: UNKNOWN